Dr. Michael A. Apostolis, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 18
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 314
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
OH license 35-099705 -
Critical Care Medicine (Internal Medicine) Physician
OH license 35-099705
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Magee Womens Hospital of UPMC Health System Pittsburgh, PA
- Independence Health System Butler Memorial Hospita Butler, PA
- Independence Health System Clarion Hospital Clarion, PA
Medical groups
- Butler Medical Providers (360 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 314
- Services billed
- 718
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 146 | 69 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 108 | 61 |
| Test for exercise-induced lung stress | 92 | 83 |
| Established patient office or other outpatient visit, 30-39 minutes | 83 | 63 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 74 | 46 |
| Test to examine how well the lungs exchange gases | 74 | 74 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 67 | 67 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 61 | 60 |
| New patient office or other outpatient visit, 45-59 minutes | 50 | 50 |
| Test to determine lung volumes using sensors | 49 | 49 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Pittsburgh, PA | 247 |
| Montelukast Sodium Other prescribers in Pittsburgh, PA | 134 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Pittsburgh, PA | 127 |
| Omeprazole Other prescribers in Pittsburgh, PA | 101 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Pittsburgh, PA | 90 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Pittsburgh, PA | 78 |
| Azelastine Hcl Other prescribers in Pittsburgh, PA | 51 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Pittsburgh, PA | 40 |
| Fluticasone Propionate Other prescribers in Pittsburgh, PA | 34 |
| Famotidine Other prescribers in Pittsburgh, PA | 23 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 102 payments worth $4,808 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $2,575 |
|---|---|
| Ethicon Inc. | $868 |
| Regeneron Healthcare Solutions, Inc. | $178 |
| Galvanize Therapeutics, Inc | $175 |
| GlaxoSmithKline, LLC. | $171 |
| Siemens Medical Solutions USA, Inc. | $136 |
| Insmed, Inc. | $125 |
| Pulmonx Corporation | $114 |
| Food and Beverage | $2,563 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $2,200 |
| Education | $45.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| AstraZeneca Pharmaceuticals LP Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $100 |
| Insmed, Inc. Jun 6, 2025 | Education in-kind | $45.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.